Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
Liyuan Zhao, Zixuan Yang, Minhui Zheng, Lei Shi, Mengyun Gu, Gang Liu, Feng Miao, Yan Chang, Huang Fanghua, Naping Tang
Abstract
In recent years, significant breakthroughs have been made in the field of gene therapy. Adeno-associated virus (AAV) is one of the most promising gene therapy vectors and a powerful tool for delivering the gene of interest. Among the AAV vectors, AAV serotype 8 (AAV8) has attracted much attention for its efficient and stable gene transfection into specific tissues. Currently, recombinant AAV8 has been widely used in gene therapy research on a variety of diseases, including genetic diseases, cancers, autoimmune diseases, and viral diseases. This paper reviewed the applications and challenges of using AAV8 as a vector for gene therapy, with the aim of providing a valuable resource for those pursuing the application of viral vectors in gene therapy.